Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aegerion Pharmaceuticals, Inc sees FY 2014 revenue guidance toward lower end of prior range


Tuesday, 29 Jul 2014 04:15pm EDT 

Aegerion Pharmaceuticals, Inc:Expects FY 2014 net product sales to be toward the lower end of the previously stated guidance range of between $180 and $200 million. 

Related Company News

Company Quote

21.59
-0.27 -1.24%
24 Dec 2014